Participate in the Healthcare AI Challenge at ACR 2025
Call for ACR 2025 attendees to participate in healthcare AI challenge at the upcoming meeting.
Read moreACR Data Science Institute’s AI Central has been updated with a new PRO Platform manufacturer and two new products to the directory.
Aidoc Medical, Ltd. joined our AI Central PRO program this month and added their platform, Aidoc aiOS, to the directory. Aidoc aiOS helps health systems overcome the challenges of AI adoption with a single, unified medical AI platform.
AI Central PRO allows manufacturers to add additional information to their manufacturer and product profiles on AI Central to explain how their products work in an effort to improve patient care and make it easier to learn more. This gives radiologists a better understanding of how a product can best support their patients and workflows through supplemental material about each product developed by the manufacturer.
Aidoc Medical, Ltd. also have five products in our Transparent-AI program: BriefCase-Aortic Dissection Triage, BriefCase-Pneumothorax Triage, BriefCase-Pulmonary Embolism Triage, BriefCase-Rib Fracture Triage, and BriefCase-Intra-abdominal Free Gas Triage.
Transparent-AI is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population. The program consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with two new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see newly cleared FDA products designed for pediatric x-rays, chest CTs and prostate MR images.
New products include:
Participate in the Healthcare AI Challenge at ACR 2025
Call for ACR 2025 attendees to participate in healthcare AI challenge at the upcoming meeting.
Read moreEnhancements to FDA Draft AI Guidance
ACR® provided comments to the U.S. FDA regarding the draft guidance to address risk management approaches throughout the lifecycle of AI-enabled medical devices.
Read moreProhibition on Discrimination
Covered entities must make reasonable efforts to identify uses of patient care decision support tools in their health programs and activities that employ input variables or factors that measure race, color, national origin, sex, age or disability.
Read more